PETX
Aratana Therapeutics, Inc.
PETX
PETX
Delisted
PETX was delisted on the 17th of July, 2019.
92 hedge funds and large institutions have $429M invested in Aratana Therapeutics, Inc. in 2015 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 36 increasing their positions, 24 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 93 → 92 (-1)
5% less capital invested
Capital invested by funds: $452M → $429M (-$22.6M)
Holders
92
Holding in Top 10
2
Calls
$304K
Puts
$30K
Top Buyers
| 1 | +$5.65M | |
| 2 | +$4.71M | |
| 3 | +$4.54M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.54M |
| 5 |
SCM
Sio Capital Management
New York
|
+$3.42M |
Top Sellers
| 1 | -$13.3M | |
| 2 | -$6.01M | |
| 3 | -$3.66M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.27M |
| 5 |
TCM
Tygh Capital Management
Portland,
Oregon
|
-$1.73M |